Loading organizations...
Loading organizations...
Genetic medicine technology for precise gene expression modulation.
Epic-Bio has raised $123.0M across 2 funding rounds.
Epic-Bio has raised $123.0M in total across 2 funding rounds.
Epic-Bio has raised $123.0M in total across 2 funding rounds.
Epic-Bio's investors include Ally Bridge Group, Horizons Ventures.
Epic-Bio has raised $123.0M across 2 funding rounds. Most recently, it raised $68.0M Series B in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 26, 2025 | $68.0M Series B | Ally Bridge Group | |
| Jul 12, 2022 | $55.0M Series A | Horizons Ventures |